Transforming Animal Venom into Lifesaving Medication
A special issue of Toxins (ISSN 2072-6651). This special issue belongs to the section "Animal Venoms".
Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 548
Special Issue Editors
Interests: TCM therapy; neurology; stroke; epilepsy
Interests: herbal safety; toxicology; TCM pharmaology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Technological advancements have effectively transformed life-threatening animal venom into lifesaving therapeutics. Nevertheless, envenomation remains a deadly problem as not all toxin targets have been identified yet and we lack a complete understanding of the molecular pathways involved in the effects of toxins. Lead compounds for new drugs are continually emerging from research exploring the therapeutic potential of different animal venom components. These new drugs are derived from venom proteins and peptides. Some of these drugs are in clinical use while others are in developmental stages.
We invite researchers to submit original research and review articles covering significant developments in animal venom-derived drugs and diagnostic tools. The aim of this Special Issue of Toxins is to provide our readers with the most recent updates in this research field.
Dr. Ching-Liang Hsieh
Dr. Su-yin Chiang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- animal venom
- animal toxins
- scorpion
- Centipede
- Toad
- spider
- marine snail
- jelly fish
- sea anemone
- therapeutic agents
- venom diagnostic tools
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
